Genetic and immune testing program for advanced cancers
Part of Cancer clinical trials.
This program gathers tumor samples to study their genetic and immune (immune-system) features across many types of advanced cancer. Your information and tumor testing may help researchers understand which tumor features are present and how they relate to cancer behavior.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have an advanced cancer that has spread or grown locally (confirmed by pathology on tissue or cells).
- A tumor sample is available for testing—either an old stored sample or a new biopsy you can safely repeat.
- Your biopsy (if needed) must be from an accessible tumor area seen on scans; brain and bone lesions usually can’t be used.
- You are currently on the 1st, 2nd, or 3rd treatment line for advanced or metastatic cancer (simple hormone pills by themselves don’t count as a treatment line).
- If you’re over 70, your health/functional status must be excellent (ECOG 0).
- You have medical insurance and can sign the consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses advanced testing (molecular profiling and imaging) to better understand cancers and help guide treatment. It is for people with certain advanced cancers who have not yet had immunotherapy or targeted therapy.
This trial looks at your tumor’s genetic information from stored tissue to help match you to early-phase treatment options. It may help doctors find a therapy that fits your tumor, especially when standard options have limited benefit.
This study uses gene testing on stored tumor tissue (and a blood sample) to help doctors recommend treatment options that may fit your tumor’s specific changes. It may also help avoid certain medicines and share your de-identified data with other researchers.
This study looks at your tumor’s genetic information to help match you to targeted treatments when standard options are no longer working. You may be offered options based on results, with the goal of helping people with incurable, worsening cancer.
This study uses advanced DNA testing on tumor samples to help match cancer treatments more precisely. It may help researchers learn which cancer changes are driving your tumor and how they relate to treatment choices.
This study tests whether analyzing the DNA of your tumor (from a tissue sample or blood draw) can help find the best treatment for your advanced cancer. Researchers will look for genetic changes that could make you eligible for targeted therapy or a clinical trial.
Hear when a new Neoplasms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.